SCHEMBL17875987

SCHEMBL17875987

O=S1(=O)Cc2ccc(-c3ccc4oc5ccccc5c4c3)cc2-c2cc(-c3cccc4c3oc3ccccc34)ccc2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.50
PRKDC P78527 6/20 0.43
GGPS1 O95749 1/20 0.41
PTGES2 Q9H7Z7 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
ATM Q13315 1/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
PLA2G2A P14555 2/20 0.35
PLA2G4A P47712 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875924 0.96 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2SMN1; SMN2
SCHEMBL17875939 0.96 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2SMN1; SMN2
SCHEMBL17875989 0.94 ALOX5 (0.56) ALOX5PRKDCGGPS1PTGES2MEN1
SCHEMBL17875988 0.93 PRKDC (0.50) ALOX5PRKDCGGPS1PTGES2SMN1; SMN2
SCHEMBL17875990 0.91 ALOX5 (0.50) ALOX5PRKDCGGPS1PTGES2SMN1; SMN2
SCHEMBL17876000 0.90 KMT2A (0.45) SMN1; SMN2KDM4EMEN1NPC1ALDH1A1
SCHEMBL17875991 0.90 ALOX5 (0.49) ALOX5PRKDCGGPS1PTGES2ATM
SCHEMBL17875928 0.89 ALOX5 (0.51) ALOX5PRKDCGGPS1PTGES2MEN1
SCHEMBL17876002 0.89 MEN1 (0.38) ALOX5PRKDCSMN1; SMN2KDM4EMEN1
SCHEMBL17875932 0.89 PRKDC (0.47) ALOX5PRKDCGGPS1PTGES2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 ALOX5 3059/4885PRKDC 4858/4885GGPS1 1622/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 3059/4885PRKDC 4858/4885GGPS1 1622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.